Navigation Links
Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
Date:1/31/2013

KANSAS CITY, Kan. and BOSTON, Jan. 31, 2013 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced it has closed on a $12 million Series C financing.  Proceeds will fund the continued expansion of Aratana's pipeline of companion animal therapeutic products.  Existing Aratana investors, as well as new investors, participated in the over-subscribed financing.

"Aratana is on a strong growth trajectory," stated Steven St. Peter , M.D., President and Chief Executive Officer of Aratana Therapeutics.  "As we focus on advancing our current development pipeline toward approval and commercialization, we will use funds from this round to add to our portfolio of animal health products, ensuring Aratana's future growth.  We thank our investors for their support and enthusiasm and together we look forward to continued successful execution from our expert senior development and commercial team."

About Aratana Therapeutics

Aratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).  Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market.  For more information, please visit www.aratanatherapeutics.com.

For Investors & Media:
Joshua Drumm , Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com
amielach@tiberend.com


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
2. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
3. Aratana to Participate in Leerink Swanns November Management Access Days
4. Aethlon Medical Discloses CEO Interview
5. Wright Therapy Products, Inc. Closes $3 million Financing Round
6. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
7. Edison Pharmaceuticals Closes $20M Series F Financing
8. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
9. Novelos Therapeutics Closes $2 Million Private Placement
10. RxAnte Closes Series A Financing
11. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 FinancialBuzz.com ... ... leading publisher of cannabis market research, the legal cannabis market ... CAGR through 2021, despite conflicting signals from the current presidential ... out that the two biggest drivers of growth in this ...
(Date:3/24/2017)... Research and Markets has announced the addition of ... to their offering. ... IPF pipeline is very strong with a total of 97 drug candidates. ... and Sanofi are involved in the development of the IPF therapeutics. The ... Phase III stage, 15 are in Phase II stage, 12 are in ...
(Date:3/24/2017)... March 24, 2017 A ReportsnReports.com report says, ... growing rapidly as the global sales of Adcetris and Kadcyla have ... the antibody drug conjugates market is driven by large number of ... wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 Major ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation lab specializing in ... a Greenville, South Carolina location. The lab has set up shop at ... been working with South Carolina clients for years from our office here in Atlanta,” ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek ... services to families and business owners across eastern Michigan, is connecting with the ... struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ensure ...
(Date:3/24/2017)... ... March 24, 2017 , ... On June 9, 2017, ... Claims Litigation seminar in Chicago, Illinois. She will present on: , Filing ... litigated under ERISA involve claims for long-term disability benefits. This session will ...
(Date:3/24/2017)... Frederick, Maryland (PRWEB) , ... March 24, 2017 ... ... LLC, is the first Certified Medical Reiki™ Master in Frederick, MD. Judy says, ... and their caregivers during what is often a very difficult and challenging time.” ...
(Date:3/24/2017)... ... 24, 2017 , ... “The Adventures of Joey, The Dog Who Barks at ... his life to the fullest, as God intended. “The Adventures of Joey, The Dog ... and grandmother pursuing her passion for writing, especially about truth and human behavior. , ...
Breaking Medicine News(10 mins):